Hyperliquid Strategies Inc. (PURR)
| Market Cap | 866.53M |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 123.97M |
| PE Ratio | n/a |
| Forward PE | 9.40 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,876,316 |
| Open | 6.78 |
| Previous Close | 7.14 |
| Day's Range | 6.54 - 7.22 |
| 52-Week Range | 3.01 - 7.37 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 8.11 (+16.02%) |
| Earnings Date | May 7, 2026 |
About PURR
Hyperliquid Strategies Inc. operates as a digital asset treasury company focused on the blockchain and cryptocurrency sector. The company provides investors exposure to the HYPE token through treasury management strategies, such as token accumulation, staking, and yield optimization within the Hyperliquid ecosystem. The company was incorporated in 2025 and is based in New York, New York.
Analyst Summary
According to 4 analysts, the average rating for PURR stock is "Strong Buy." The 12-month stock price target is $8.11, which is an increase of 16.02% from the latest price.
News
Hyperliquid Strategies price target raised to $8 from $6 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Hyperliquid Strategies (PURR) to $8 from $6 and keeps an Overweight rating on the shares. Hyperliquid Strategies is one of the most…
Hyperliquid Strategies Earnings Call Transcript: Q3 2026
Q3 saw strong net income driven by HYPE token appreciation and effective treasury management, with expanded ecosystem participation through a new validator and rapid adoption of real world asset and outcome markets. Cash reserves remain robust, and capital allocation is flexible.
Hyperliquid Strategies, Unit Labs announce validator on Hyperliquid
Hyperliquid Strategies (PURR) and Unit Labs announced the launch of a new validator operating under the name Hyperliquid Strategies x Unit, expected to go live on or around May 11,…
Hyperliquid Strategies Inc Reports Financial Results for the Quarter Ended March 31, 2026
NEW YORK, May 7, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI" or the "Company"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem, today report...
Hyperliquid Strategies and Unit Labs Announce Validator on Hyperliquid
NEW YORK, May 7, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem, and Unit Labs ("UNIT"), the p...
Hyperliquid Strategies Inc Announces Webcast to Discuss Results for the Fiscal Quarter Ended March 31, 2026
NEW YORK, April 28, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI" or the "Company"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem, today ann...
Hyperliquid Strategies initiated with a Buy at Maxim
Maxim analyst Matthew Galinko initiated coverage of Hyperliquid Strategies (PURR) with a Buy rating and $10 price target The company’s digital asset treasury is built around the Hyperliquid ecosystem,...
Hyperliquid Strategies initiated with a Buy at Maxim
Maxim initiated coverage of Hyperliquid Strategies (PURR) with a Buy rating and $10 price target
Hyperliquid Strategies begins trading options in Nasdaq Options Market
Hyperliquid Strategies (PURR) announced that options trading on its common stock has commenced on the Nasdaq Options Market. This development enhances liquidity, price discovery, and investor access t...
Hyperliquid Strategies Inc. Announces Milestone with Launch of Options Trading on PURR Common Stock
NEW YORK, March 24, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI" or the "Company"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem, today ann...
One new option listing and sixteen option delistings on March 24th
New option listings for March 24th include Hyperliquid Strategies Inc Common Stock (PURR). Option delistings effective March 24th include Alexander & Baldwin Inc (Hawaii) (ALEX), Tradr 2X Long AUR Dai...
Hyperliquid Strategies price target raised to $6 from $5 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Hyperliquid Strategies (PURR) to $6 from $5 and keeps an Overweight rating on the shares. Hyperliquid Strategies reported its first public-quarter r...
Hyperliquid Strategies Earnings Call Transcript: Q2 2026
NAV per share accretion remains the top priority, with $140M deployed in HYPE tokens and share buybacks. Despite a $318M net loss driven by HYPE price declines, strong cash reserves and platform growth position the company for continued execution and transparency.
Hyperliquid Strategies Inc Reports Financial Results for the Quarter Ended December 31, 2025
NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI" or the "Company"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem, today repo...
Hyperliquid Strategies Inc Announces Webcast to Discuss Results for the Quarter Ended December 31, 2025
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI" or the "Company"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem, today annou...
Hyperliquid Strategies initiated with a Buy at Chardan
Chardan initiated coverage of Hyperliquid Strategies (PURR) with a Buy rating and $8.15 price target
Cantor starts Hyperliquid treasury company Hyperliquid Strategies at Overweight
As previously reported, Cantor Fitzgerald analyst Brett Knoblauch initiated coverage of Hyperliquid (HYPE-USD) Strategies (PURR) with an Overweight rating and $5 price target Hyperliquid Strategies is...
Hyperliquid Strategies initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of Hyperliquid Strategies (PURR) with an Overweight rating and $5 price target
Hyperliquid Strategies Inc Announces $30 million Stock Repurchase Program
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Hyperliquid Strategies Inc (NASDAQ: PURR) (“HSI” or the “Company”) announced today that its Board of Directors has authorized a stock repurchase program of ...
Ex-Barclays CEO unpacks Hyperliquid: ‘The FUTURE of finance'
Hyperliquid Strategies Inc. chairman Bob Diamond and Hyperliquid Stategies Inc. CEO David Schamis comment on the future of Hyperliquid Strategies Inc. on ‘The Claman Countdown.'
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wednesday, December 3 Under the Ticker “PURR” Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wedn...
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has adjourned its special meeting of stockh...
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is collaborating with Spanios on a non-clinical study using New Alternate Methodologies (NAM)-based patie...
Sonnet to Present at the MedInvest Biotech & Pharma Conference
PRINCETON, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targete...
Sonnet Releases Virtual Investor "What This Means" Segment
- Dr. Richard Kenney, Chief Medical Officer of Sonnet, discusses the recently announced expansion of its clinical study of patients with platinum-resistant ovarian cancer (PROC) (SB221)